Doc said "Only a sociopath can work in mass therapy".

Published Date: 02 Mar 2023

Many doctors have accused hospitals and large hospitals of opposing quality care and promoting violence. Others disagree.

Read Full News

Latest News

Hospital Doctors Plan 24-Hour Walkout in Victoria, Australia

The walkouts are the next stage of the doctors’ effort to improve what they call long hours and poor working conditions.

West Nile Virus Infections Cause Three Deaths in the Netherlands

Three people in the Netherlands have died from ⁠an infection caused by the West Nile virus in recent weeks, ⁠the country's public health institution RIVM said on Thursday,...

Chronic Low Back Pain: Do Lumbar Braces Deliver?

Lumbar braces modestly ease chronic low back pain when paired with NSAIDs, but low-certainty evidence and missing safety data means their role in routine care remains unclear.

Bangladesh Fights World's Worst Measles Outbreak as Vaccination Gaps Fuel Spread

Bangladesh, which once came close to eliminating measles, is facing its worst outbreak on record, with 999 suspected and confirmed measles-related deaths reported since...

Switching Dialysis Modalities Ups Mortality in Older Adults

Switching from peritoneal dialysis to hemodialysis is independently associated with increased mortality risk in adults aged 80 years or older.

Shifting the Weight-Loss Focus: More Than Pounds Lost

Every new weight-loss medication seems to promise a greater quantity of weight loss, but growing numbers of experts say it’s crucial to balance quality with quantity of weight loss.

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Latest News

The walkouts are the next stage of the doctors’ effort to improve what they call long hours and poor working conditions.

Three people in the Netherlands have died from ⁠an infection caused by the West Nile virus in recent weeks, ⁠the country's public health institution RIVM said on Thursday,...

Lumbar braces modestly ease chronic low back pain when paired with NSAIDs, but low-certainty evidence and missing safety data means their role in routine care remains unclear.

Bangladesh, which once came close to eliminating measles, is facing its worst outbreak on record, with 999 suspected and confirmed measles-related deaths reported since...

Switching from peritoneal dialysis to hemodialysis is independently associated with increased mortality risk in adults aged 80 years or older.

Every new weight-loss medication seems to promise a greater quantity of weight loss, but growing numbers of experts say it’s crucial to balance quality with quantity of weight loss.

News All Time

Ultrasound Expands Options for Chest Lesion Biopsy

A radiation-sparing procedure shows a safe and effective diagnostic potential.

Irish Health Service Operator Fined for Storing Data in Disused Bathroom, Turf Shed

Ireland's health service operator was fined a record amount for an Irish public body by the country's data regulator ⁠for storing medical records in "profound disarray" in...

How to Differentiate the Major Subtypes of ILD

The definitions of interstitial lung disease subtypes have undergone major revisions, encompassing clinical, radiologic, and histologic findings, as well as a few new categories.

Long-Term Primary Care Saves Lives — and Is Hard to Achieve

New research quantifies the benefits of long-term patient relationships. How can you build them in a system that prioritizes high-volume access?

Size Matters for Chest Tubes

New data show similar outcomes with large-bore and small-bore chest tubes in patients with pneumothoraces.

UnitedHealthcare to Drop Prior Authorization Requirements for Range Of Conditions From Oct. 1

UnitedHealth's insurance unit said on Tuesday that a broad range of conditions will no ⁠longer need prior approval, effective October 1, as it aims to eliminate prior...

Rilzabrutinib May Be Promising in IgG4-Related Disease

Rilzabrutinib treatment is associated with a reduction in disease activity in patients with IgG4-related disease and enables most patients to discontinue glucocorticoids without experiencing flares.

What to Know About ‘Musculoskeletal Syndrome of Menopause’

Is new joint pain in perimenopause simple arthralgia or underlying inflammatory arthritis? Learn key diagnostic steps, seronegative RA risks, and hormone replacement therapy insights.

Strategies to Optimize Sepsis Outcomes

Multi-society position paper presents strategies for improvement at the hospital and systems level.

MRI Pattern May Forecast MCI to Dementia Timeline

An MRI-defined pattern of cortical atrophy may help identify patients with early-onset Alzheimer’s disease at risk for more rapid progression from MCI to dementia.

At-Home Lecanemab: What Does It Mean for Alzheimer’s Care?

At-home subcutaneous lecanemab may ease the burden of frequent infusions, but clinicians still face key questions about patient selection, training, ARIA monitoring, adherence, and access.

Paternal Valproate Use Not Tied to NDDs in Offspring

Paternal exposure to valproate during spermatogenesis is not tied to a risk for neurodevelopmental disorders or congenital malformations in offspring, research shows.

Early Oseltamivir Tied to Lower Hospitalization Risk in Flu

Among adult veterans, oseltamivir treatment initiated within 6 hours of influenza diagnosis is associated with a reduced risk for hospitalization.

AI Outperforms Gene Sequencing for Lung Nodule Triage

Interpret findings with caution, but AI-based radiomics may help curb unnecessary procedures.

Discharge Support Remains Weak Spot in CQC Patient Survey

The CQC's 2025 survey of 58,000 patients found rising satisfaction overall, but discharge planning remains an area of difficulty.

Are Universal Digital Mental Health Interventions Effective?

In children without diagnosed mental health conditions, digital interventions are associated with small psychological improvements.

Recommended News For You

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Clinical trial is testing whether heavy lifting could combat cancer side effects

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

A healthier lifestyle after bowel screening shown to prevent bowel cancer

Recommended Articles For You

Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy 

Hematopoietic Microenvironment Rejuvenation Through Cellular Architecture Remodeling 

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions 

Engineered Hematopoietic Cells for Targeted Correction of Abnormal Blood-Cell Production 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Sevabertinib Approved for First-Line Mutated NSCLC

2.

Top 10 questions about breast cancer answered

3.

Inadvertent lung cancer screening results are discussed in a new study.

4.

United States Lung Cancer Screening Rates Remain Low. s. in particular in the South.

5.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

1.

Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain

2.

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025

3.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

4.

A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer

5.

CA-125 Test: Why It's Important for Women's Health and Early Detection of Ovarian Cancer

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

3.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

5.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot